Perovic et al. (54) assessed differences in resistin and copeptin concentration between 112 ischemic stroke patients and 63 healthy controls, but also assessed whether these markers have any prognostic value for ischemic volume, stroke severity (measured by NIHSS score) and patients’ functionality (measured by Barthel Index). This evidence concerns the gene AVP and stroke disorder.